DR REDDYS LABORATORIES
|
|
BOM : 500124     NSE : DRREDDY     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Sep 06,2024 |
Price(EOD): ₹ 6,669.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 111,318.13 Cr |
Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in India. The company manufactures and markets a wide range of pharmaceuticals in India and overseas. The company's business is divided into three main segments: Global Generics, Pharmaceutical S... Read More >
Industry Peers & Returns | 1W | 1M | 1Y |
DR REDDYS LABORATORIES | -2.9% | -3.7% | 20.1% |
SUN PHARMACEUTICAL INDUSTRIES | 0.4% | 5.1% | 64.6% |
CIPLA | -2.1% | 3.7% | 30.8% |
ZYDUS LIFESCIENCES | -1% | -13.6% | 81.7% |
DIVIS LABORATORIES | 2.1% | 3.9% | 42.8% |
MANKIND PHARMA | 1.3% | 17.9% | 43.2% |
FUNDAMENTAL ANALYSIS OF DR REDDYS LABORATORIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DR REDDYS LABORATORIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
20.06
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 5,549.00 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 3.96
P/B Calculated based on Book Value of Rs 28,123.50 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.84
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 28,949.30 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
15% 9% 14% |
SHARE PRICE MOMENTUM OF DR REDDYS LABORATORIES
DR REDDYS LABORATORIES vs SENSEX
DEBT OF DR REDDYS LABORATORIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.03 0 0.12 0.05 |
0.07 0.06 0.18 0.1 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DR REDDYS LABORATORIES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DR REDDYS LABORATORIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
8.19% 16.31% 17.17% 6.14% |
13.88% 3.29% 1.68% -1.01% |
QtrlyTrend |
6 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
DR REDDYS LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE CARBONEX | 1.5% | 1.4% | 34.5% |
S&P BSE HEALTHCARE | 0.7% | 8.6% | 55.8% |
S&P BSE LOW VOLATILITY | -0.4% | 2.6% | 38.3% |
S&P BSE ALLCAP | -1.1% | 4.7% | 39.1% |
S&P BSE 500 | -1.1% | 4.5% | 38% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY GROWTH SECTOR 15 | 1.2% | 11.6% | 9.1% |
NIFTY100 LOW VOLATILITY 30 | -0.1% | 4.6% | 39.6% |
NIFTY QUALITY LOW-VOLATILTY 30 | -0.1% | 4.6% | 36.9% |
NIFTY HEALTHCARE | -0.4% | 6.4% | 52.5% |
NIFTY ALPHA QTY LOW-VOLAT.30 | -0.5% | 4.1% | 57.5% |
You may also like the below Video Courses
FAQ about DR REDDYS LABORATORIES
Is DR REDDYS LABORATORIES good for long term investment?
As on Sep 06,2024, the Fundamentals of DR REDDYS LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of DR REDDYS LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DR REDDYS LABORATORIES UnderValued or OverValued?
As on Sep 06,2024, DR REDDYS LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of DR REDDYS LABORATORIES ?
As on Sep 06,2024, the Intrinsic Value of DR REDDYS LABORATORIES is Rs. 5,874.28 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 5,794.40
Fair Value [Median EV / Sales Model] : Rs. 6,097.84
Fair Value [Median Price / Sales Model] : Rs. 5,874.28
Estimated Median Fair Value of DR REDDYS LABORATORIES : Rs. 5,874.28
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.